Table 3.
adherence to statin treatment for new users
| Type of indicator | Parameters | One risk factor (statin alone) |
Two risk factors* | At least three risk factors* |
|---|---|---|---|---|
| n= | 3,560 | 5,072 | 7,765 | |
| Medication availability | CMA, mean % [CI95] | 56 [54.7;57.2] | 64.4 [63.4;65.5] | 72.2 [71.9;73.6] |
| CMA < 80%, n (%) | 2,378 (67.0) | 2,889 (57.0) | 3,361 (43.3) | |
| Persistence |
Cumulative rate for persistence at 15 months % [CI95] |
44.3 [42.7;45.9] | 50.1 [48.7;51.5] | 59.4 [58.3;60.5] |
| Regularity | CMG, mean % [CI95] | 33.4 [32.5;34.3] | 29.2 [28.5;29.9] | 23.2 [22.7;23.8] |
| Refill delay | mean [CI95], days | 31.4 [31.0;31.8] | 30.2 [29.9;30.5] | 28.6 [28.3;28.8] |
CMA: Continuous Multiple-interval measures of medication Availability; CMG: Continuous Multiple-interval measures of medication Gaps.
*: other risk factors include age, diabetes mellitus and cardiovascular co-morbidities